Emerging Markets Growth Fund, Inc. Class F-3 (EMGEX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
7.56
+0.02 (0.27%)
Jun 5, 2025, 4:00 PM EDT
12.33% (1Y)
| Fund Assets | 2.30B |
| Expense Ratio | 0.73% |
| Min. Investment | $250 |
| Turnover | n/a |
| Dividend (ttm) | 0.10 |
| Dividend Yield | 1.34% |
| Dividend Growth | 3.90% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 7.54 |
| YTD Return | 13.51% |
| 1-Year Return | 12.33% |
| 5-Year Return | 20.75% |
| 52-Week Low | 6.20 |
| 52-Week High | 7.57 |
| Beta (5Y) | n/a |
| Holdings | 141 |
| Inception Date | Sep 1, 2017 |
About EMGEX
The Emerging Markets Growth Fund, Inc. Class F-3 (EMGEX) seeks to provide holders of the Fund's common shares with a high level of current income exempt from federal income tax, consistent with preservation of capital.
Category Diversified Emerging Mkts
Stock Exchange NASDAQ
Ticker Symbol EMGEX
Share Class Class F-3
Index MSCI Emerging Markets IMI NR USD
Performance
EMGEX had a total return of 12.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.39%.
Top 10 Holdings
30.98% of assets| Name | Symbol | Weight |
|---|---|---|
| TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 2330 | 8.29% |
| TENCENT HOLDINGS LTD | 0700 | 5.18% |
| CAPITAL GROUP CENTRAL CASH FUND | CMQXX | 3.04% |
| Kimberly-Clark Corporation | KMB | 2.38% |
| NETEASE INC | 9999 | 2.21% |
| SHENZHEN INOVANCE TECHNOLOGY CO LTD A (SZSE NORTH) | 300124 | 2.18% |
| INNOVENT BIOLOGICS INC | 1801 | 2.12% |
| MEITUAN CL B | 3690 | 1.97% |
| PING AN INSURANCE GROUP CO OF CHINA LTD CL H | 2318 | 1.82% |
| BeOne Medicines Ltd. | ONC | 1.79% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $0.1013 | Dec 24, 2024 |
| Dec 21, 2023 | $0.0975 | Dec 22, 2023 |
| Dec 22, 2022 | $0.0816 | Dec 23, 2022 |
| Dec 22, 2021 | $0.9361 | Dec 23, 2021 |
| Dec 22, 2020 | $0.6193 | Dec 23, 2020 |
| Dec 26, 2019 | $0.4848 | Dec 27, 2019 |